Brief: Shilpa Medicare Says Received Approval For Manufacture And Sale Of Oral Mucositis Spray
11/10/2023 15:40
Oct 11 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* RECEIVED APPROVAL FROM OFFICE OF DIRECTORATE OF AYURVEDA
AND
UNANI SERVICES
* RECEIVED APPROVAL FOR MANUFACTURE AND SALE OF ORAL
MUCOSITIS
SPRAY
Source text for Eikon: ID:nNSE8rj3Dh
Further company coverage: SHME.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026